Description
Company Overview
Rhythm is a global, commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with rare neuroendocrine diseases. We develop medicines for previously untreatable or undertreated diseases and provide meaningful support for healthcare providers and patients and their families. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to adapt, learn, and our tenacity to overcome barriers, together.
Opportunity Overview
The Patient Education Manager is a field-based member of the commercial team. In this role, you will be responsible for supporting the patient-centric business model, responding to the needs of patients and caregivers through engagement, education, care coordination and resolution of treatment access related barriers. You will establish strong relationships with people living with rare genetic diseases of obesity (RGDO) and their caregivers, serving as an integral resource throughout their journey. Further, you will provide support and connect patients and health care providers to the resources they need, to optimize patient care, while working collaboratively within a team environment. This role reports into US Patient Services Director, West.
Your territory will cover the following states in the Central region: Illinois, Wisconsin, Minnesota, Michigan, North Dakota and South Dakota, and the location is flexible within the territory. Note that the territory may change as our business needs evolve.
Responsibilities and Duties
Deliver in-depth disease state and product education to support and empower patients/caregivers as they navigate treatment access
Identify and resolve patient specific barriers and develops action plans for resolution to allow patients/caregivers to manage their disease and treatment as recommended by their healthcare provider
Responsible for delivery of education programs (in person and virtual) to patients and families affected by RGDO
Provide care coordination for patients/caregivers working as a liaison with the Field Access Manager and Territory Manager/ Sales to help facilitate the reimbursement and fulfillment process
Effectively collaborate with cross functional partners to solve complex patient and customer issues
Respond to all customer inquiries, provide appropriate education and support and triage to available resources
Maintain comprehensive understanding of regional trends (payor and customer)
Meet documentation requirements to facilitate tracking of critical metrics
Ensure full compliance with all corporate and industry policies and legal and regulatory requirements for all regional commercial activities
Qualifications and Skills
Bachelor's degree required, nursing, social work, dietitian, or clinical background preferred
6+ years of related experience, including supporting patients within Rare Disease
Knowledge of insurance and payor landscape and US reimbursement process
Prior product launch experience preferred
Ability to work quickly and flexibly with resource constraints, exhibiting a results-drive mindset
Ability to work both independently and collaboratively with a diverse team
Ability to travel in the U. S. (up to 50% travel)
This role is field-based. Candidates applying must be willing and able to travel frequently and have easy access to transportation and airports.
More About Rhythm
Our lead asset, IMCIVREE® (setmelanotide), is a precision medicine designed to treat hyperphagia, an insatiable, pathological hunger characterized by abnormal food-seeking behaviors, and early- or rapid-onset severe obesity caused by an impairment of a pathway in the hypothalamus called the melanocortin-4 receptor (MC4R) pathway. IMCIVREE® is the first and only approved therapy for certain rare MC4R pathway diseases in the United States, Europe, Great Britain and several other countries. In collaboration with leading experts across the world, Rhythm is advancing the most comprehensive clinical research program ever initiated in MC4R pathway diseases, including a Phase 3 trial for acquired hypothalamic obesity. In addition, we are leveraging our extensive genetic database, global network of researchers, a track record of regulatory successes and global commercial infrastructure to develop a full portfolio of treatment options to patients struggling with hyperphagia and severe obesity and ensuring they get the treatment that is right for them.
We continue to advance care and precision medicines that address rare diseases. We are focused on expanding access to IMCIVREE® to reach more patients and developing novel therapies for other rare neuroendocrine diseases, including congenital hyperinsulinism. Rhythm's headquarters is in Boston, MA.
Powered by JazzHR
Compensation Information:
$0.0 / - $0.0 /
Starting At: 0.0
Up To: 0.0
Apply on company website